This study demonstrated that PAF1 is required for the YAP1-mediated PC development, and CA3 and verteporfin, inhibitors of YAP1/TEAD4 transcriptional activity, target the PAF1/YAP1/SOX9 axis to attenuate the development of PC. The gene discussed is YAP1; the disease is pachyonychia congenita.